and other drugs subject to deterioration Supplying non-prescription medicines, and diagnostic and therapeutic
and other drugs subject to deterioration Supplying non-prescription medicines, and diagnostic and therapeutic
action plans and improvements in the resolution of non-compliance with standards detected through monitoring